KCM
Kendall Capital Management Portfolio holdings
AUM
$378M
This Quarter Return
-2.21%
1 Year Return
+20.29%
3 Year Return
+77.27%
5 Year Return
+155.33%
10 Year Return
–
AUM
$226M
AUM Growth
+$226M
(-1.1%)
Cap. Flow
+$6.72M
Cap. Flow
% of AUM
2.98%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
202
New
7
Increased
69
Reduced
102
Closed
8
Top Buys
| 1 |
Avnet
AVT
|
$933K |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$897K |
| 3 |
Cal-Maine
CALM
|
$751K |
| 4 |
Celestica
CLS
|
$634K |
| 5 |
Hewlett Packard
HPE
|
$547K |
Top Sells
| 1 |
WWE
World Wrestling Entertainment
WWE
|
$635K |
| 2 |
Intel
INTC
|
$317K |
| 3 |
Werner Enterprises
WERN
|
$315K |
| 4 |
Oracle
ORCL
|
$286K |
| 5 |
Arrow Electronics
ARW
|
$267K |
Sector Composition
| 1 | Technology | 22.54% |
| 2 | Healthcare | 13.16% |
| 3 | Financials | 11.37% |
| 4 | Industrials | 9.7% |
| 5 | Consumer Discretionary | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Lam Research
LRCX
$127B
| $332K | 0.15% |
530
| – | – |
|
152
Qorvo
QRVO
$8.4B
| $329K | 0.15% |
3,445
-1,425
| -29% | -$136K |
|
153
Malibu Boats
MBUU
$639M
| $322K | 0.14% |
+6,578
| New | +$322K |
|
154
Quest Diagnostics
DGX
$20.3B
| $313K | 0.14% |
2,570
-1,235
| -32% | -$150K |
|
155
Chevron
CVX
$324B
| $301K | 0.13% |
1,788
-145
| -8% | -$24.4K |
|
156
Sanofi
SNY
$121B
| $300K | 0.13% |
5,590
+1,265
| +29% | +$67.9K |
|
157
Winnebago Industries
WGO
$1.01B
| $297K | 0.13% |
5,000
-660
| -12% | -$39.2K |
|
158
Global Payments
GPN
$21.5B
| $296K | 0.13% |
2,568
| – | – |
|
159
Technology Select Sector SPDR Fund
XLK
$83.9B
| $295K | 0.13% |
1,800
-113
| -6% | -$18.5K |
|
160
Wabash National
WNC
$454M
| $292K | 0.13% |
+13,810
| New | +$292K |
|
161
Ultra Clean Holdings
UCTT
$1.09B
| $291K | 0.13% |
9,820
-700
| -7% | -$20.7K |
|
|
DOOR
162
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $287K | 0.13% |
3,080
-50
| -2% | -$4.66K |
|
163
Nu Skin
NUS
$602M
| $286K | 0.13% |
13,475
-4,275
| -24% | -$90.7K |
|
164
Cardinal Health
CAH
$35.5B
| $285K | 0.13% |
3,285
-100
| -3% | -$8.68K |
|
165
Masco
MAS
$15.4B
| $285K | 0.13% |
5,325
-35
| -0.7% | -$1.87K |
|
166
Veeco
VECO
$1.48B
| $278K | 0.12% |
9,890
-600
| -6% | -$16.9K |
|
167
Gilead Sciences
GILD
$140B
| $269K | 0.12% |
3,587
+895
| +33% | +$67.1K |
|
168
Expedia Group
EXPE
$26.6B
| $268K | 0.12% |
2,600
+770
| +42% | +$79.4K |
|
169
UGI
UGI
$7.44B
| $265K | 0.12% |
11,535
-990
| -8% | -$22.7K |
|
170
Brookfield Infrastructure
BIPC
$4.79B
| $261K | 0.12% |
7,375
-75
| -1% | -$2.65K |
|
171
D.R. Horton
DHI
$50.5B
| $261K | 0.12% |
2,428
| – | – |
|
172
Encore Capital Group
ECPG
$963M
| $258K | 0.11% |
5,395
-3,015
| -36% | -$144K |
|
173
AMC Networks
AMCX
$306M
| $252K | 0.11% |
21,360
-345
| -2% | -$4.07K |
|
174
Novartis
NVS
$245B
| $252K | 0.11% |
2,470
| – | – |
|
175
AT&T
T
$209B
| $252K | 0.11% |
16,762
-250
| -1% | -$3.76K |
|